proteasome inhibitors
Showing 1 - 25 of 4,315
Multiple Myeloma Trial in Durham (Opaganib)
Terminated
- Multiple Myeloma
-
Durham, North CarolinaDuke University Medical Center
May 24, 2021
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (Placebo, Bortezomib, Dexamethasone)
Completed
- Relapsed/Refractory Multiple Myeloma
- Placebo
- +3 more
-
Aurora, Colorado
- +96 more
Aug 22, 2022
Kidney Transplantation, End Stage Kidney Disease (ESRD) Trial in Chicago (Belatacept Injection)
Recruiting
- Kidney Transplantation
- End Stage Kidney Disease (ESRD)
- Belatacept Injection
-
Chicago, IllinoisUniversity of Chicago
May 13, 2022
Based on Maintenance Therapy Post Autologous Stem Cell
Recruiting
- Multiple Myeloma
- Autologous Stem Cell Transplant
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Jul 27, 2022
CIPN and it's Impact on Quality of Life in Patients Receiving
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 24, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Carfilzomib, Cyclophosphamide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- Carfilzomib
- +2 more
- (no location specified)
Jun 8, 2023
Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 2001
-
Benowa, Queensland, AustraliaPindara Private Hospital
May 18, 2023
Proteasome Inhibition
Completed
- Heart Failure
- Multiple Myeloma
-
Philadelphia, Pennsylvania
- +1 more
Sep 10, 2020
Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- Acute Lymphoblastic Leukemia With Failed Remission
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Sep 12, 2023
Relapsed/Refractory Multiple Myeloma Trial in Australia, United States (ISB 1442 SC injection escalating doses, ISB 1442 SC
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ISB 1442 SC injection escalating doses
- ISB 1442 SC injection at RP2D
-
New York, New York
- +5 more
Jun 17, 2022
Cardiovascular Complications of Carfilzomib Treatment
Active, not recruiting
- Multiple Myeloma
-
Athens, GreeceDepartment of Clinical Therapeutics, "Alexandra" General Hospita
Apr 27, 2021
Bendamustine, Multiple Myeloma Trial in Shenyang (Bendamustine)
Recruiting
- Bendamustine
- Multiple Myeloma
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Aug 7, 2021
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
Multiple Myeloma in Relapse Trial in Finland, Sweden (Carfilzomib for Inj 60 milligram (MG), Elotuzumab 400 MG, Dexamethasone)
Active, not recruiting
- Multiple Myeloma in Relapse
- Carfilzomib for Inj 60 milligram (MG)
- +2 more
-
Helsinki, Finland
- +7 more
Mar 14, 2022
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the
Not yet recruiting
- Multiple Myeloma
- +2 more
- 18F-fluciclovine injection
- 18F-FDG PET/CT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 31, 2023
Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)
Active, not recruiting
- Multiple Myeloma
- Auto Stem Cell Transplant
-
Hackensack, New JerseyJohn Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022
Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in Atlanta (MLN9708)
Completed
- Acute Leukemia
- +4 more
-
Atlanta, GeorgiaNorthside Hospital
Sep 1, 2021
Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)
Active, not recruiting
- Multiple Myeloma
- High-Risk Cancer
- Bortezomib following nonmyeloablative allogeneic transplant
-
Montreal, Quebec, CanadaHôpital Maisonneuve-Rosemont
Aug 22, 2022
Multiple Myeloma Trial in Netherlands (Iberdomide plus low-dose cyclophosphamide and dexamethasone)
Recruiting
- Multiple Myeloma
- Iberdomide plus low-dose cyclophosphamide and dexamethasone
-
Alkmaar, Netherlands
- +8 more
Oct 5, 2021
Multiple Myeloma, Pneumococcal Infection, Febrile Neutropenia Trial in Minsk (Vaccination with pneumococcal conjugate vaccine
Enrolling by invitation
- Multiple Myeloma
- +3 more
- Vaccination with pneumococcal conjugate vaccine (PCV13)
- Standard Antibacterial Prophylaxis
-
Minsk, BelarusMinsk Scientific Practical Center of Surgery, Transplantation an
Sep 1, 2020